New Data on First-Line Psoriasis Drug'Very Reassuring'New Data on First-Line Psoriasis Drug'Very Reassuring '
A higher cumulative dose of methotrexate taken did not increase the risk for liver fibrosis, but excess weight, metabolic syndrome, and diabetes did.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 1, 2024 Category: Dermatology Tags: Dermatology Source Type: news
Study Finds No Increased Cancer Risk With Spironolactone Study Finds No Increased Cancer Risk With Spironolactone
Over 5 years, treatment with spironolactone for dermatologic conditions was not associated with a greater risk for breast or gynecologic cancers, when compared with women not using spironolactone.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 1, 2024 Category: Dermatology Tags: Dermatology Source Type: news
What Drives Fatigue in Psoriasis and PsA? What Drives Fatigue in Psoriasis and PsA?
Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 27, 2024 Category: Dermatology Tags: Dermatology Source Type: news
Study Exposes Gaps in US Burn Center Access Study Exposes Gaps in US Burn Center Access
A recent study highlighted disparities in burn care access in the United States.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 27, 2024 Category: Dermatology Tags: Emergency Medicine Source Type: news
European Approval for Lung and Skin Cancer Drugs European Approval for Lung and Skin Cancer Drugs
The European Medicines Agency granted marketing authorization for tislelizumab and retifanlimab for the treatment of non –small cell lung cancer and Merkel cell carcinoma, respectively.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 23, 2024 Category: Dermatology Tags: Hematology-Oncology Source Type: news
EMA Approves Tx for Psoriasis and Other Autoimmune Disorders EMA Approves Tx for Psoriasis and Other Autoimmune Disorders
The biosimilar Pyzchiva is highly similar to Stelara, which was approved in the EU in 2009.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 23, 2024 Category: Dermatology Tags: Dermatology Source Type: news
' Superclinic' Powers Through Skin Cancer Referrals'Superclinic' Powers Through Skin Cancer Referrals
One hospital ' s experience with this model shows the efficiency of using a dedicated team (including trainees) and offering same-day biopsies and surgery.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 23, 2024 Category: Dermatology Tags: Dermatology Source Type: news
Longer IV Ertapenem Course Beneficial for Recalcitrant HS Longer IV Ertapenem Course Beneficial for Recalcitrant HS
2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 23, 2024 Category: Dermatology Tags: Dermatology Source Type: news
One-a-Day Pill for Alopecia Recommended for NHS Use One-a-Day Pill for Alopecia Recommended for NHS Use
NICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 22, 2024 Category: Dermatology Tags: Dermatology Source Type: news
FDA Approves First Cellular Therapy for Metastatic Melanoma FDA Approves First Cellular Therapy for Metastatic Melanoma
Lifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 16, 2024 Category: Dermatology Tags: Dermatology Source Type: news
Cellulite: Outcomes 1 Year After Noninvasive Treatment Cellulite: Outcomes 1 Year After Noninvasive Treatment
The findings build on results from a 12-week study of the device, which the investigators said " induces physical shearing of fibrous septa through rapid acoustic pulses. "MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 16, 2024 Category: Dermatology Tags: Dermatology Source Type: news
Inflammatory Arthritis Has Big Impact on Systemic Sclerosis Inflammatory Arthritis Has Big Impact on Systemic Sclerosis
In patients with SSc, the presence of inflammatory arthritis is significantly associated with diffuse disease, musculoskeletal manifestations, myositis, and sicca.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 15, 2024 Category: Dermatology Tags: Rheumatology Source Type: news
Sweetened Drinks Spell Hormone Trouble for Women Sweetened Drinks Spell Hormone Trouble for Women
Fructose intake from sugar-sweetened beverages increased risk for hyperandrogenism, but fructose intake from fruit did not.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 9, 2024 Category: Dermatology Tags: Diabetes & Endocrinology Source Type: news
Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million
The most expensive gene therapy on the US market may give payers pause, said study authors.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 8, 2024 Category: Dermatology Tags: Dermatology Source Type: news
Comorbidities Weigh Heavily in Autoimmune Pregnancy Outcomes Comorbidities Weigh Heavily in Autoimmune Pregnancy Outcomes
After controlling for other chronic conditions, certain immune-mediated inflammatory diseases were not associated with an increased risk for poor pregnancy outcomes.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 7, 2024 Category: Dermatology Tags: Rheumatology Source Type: news
